Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00044694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Short-Term, Dose-Response Study to Examine the Effect on Glucose Control and Safety and Tolerability of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, blinded, placebo-controlled, short-term, dose-response study to examine the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be individuals with type 2 diabetes treated with metformin for at least 3 months prior to screening. Patients whose diabetes management consists of diet and exercise will also be eligible for this study.
Study identification
- NCT ID
- NCT00044694
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Placebo 0.01 mL Drug
- Placebo 0.02 mL Drug
- Placebo 0.03 mL Drug
- Placebo 0.04 mL Drug
- AC2993 2.5 mcg Drug
- AC2993 5.0 mcg Drug
- AC2993 7.5 mcg Drug
- AC2993 10.0 mcg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2002 (Type not available)
- Primary completion
- May 2003 (Actual)
- Completion
- May 2003 (Actual)
- Last update posted
- Feb 20, 2015
2002 – 2003
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Innovative Clinical Trials | Birmingham | Alabama | 35209 | — |
| Healthsouth Clinical Research | Birmingham | Alabama | 35243 | — |
| Endocrinology Clinic of O.C. | Anaheim | California | 92801 | — |
| Pioneer Medical Group | Bellflower | California | 90706 | — |
| International Clinical Research Network | Chula Vista | California | 91910 | — |
| Bautista Research and Medical Clinic | Fresno | California | 93721 | — |
| Whittier Institute for Diabetes | La Jolla | California | 92037 | — |
| Richard Cherlin, M.D. | Los Gatos | California | 95032 | — |
| Dr. Martinez Medical Clinic | Moreno Valley | California | 92553 | — |
| Anshutz Outpatient Pavilion | Aurora | Colorado | 80010 | — |
| Diagnostic Clinic | Clearwater | Florida | 33760 | — |
| Radiant Research-Gainsville | Gainsville | Florida | 32605 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Radiant Research-Pinellas Park | Pinellas Park | Florida | 33781 | — |
| Clinical Research Group of North Georgia | Blairsville | Georgia | 30512 | — |
| East-West Medical Research Institute | Honolulu | Hawaii | 96813 | — |
| Radiant Research-Honolulu | Honolulu | Hawaii | 96814 | — |
| Radiant Research-Boise | Boise | Idaho | 83704 | — |
| Cedar-Crosse Research Center | Chicago | Illinois | 60607 | — |
| Northshore Medical Research, LLC | Covington | Louisiana | 70433 | — |
| Medical Research Institute | Slidell | Louisiana | 70458 | — |
| Melvin Kramer, MD | Concord | Massachusetts | 01742 | — |
| Radiant Research-Edina | Edina | Minnesota | 55435 | — |
| Mississippi Medical Research, LLC | Gulfport | Mississippi | 39501 | — |
| The Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Innovative Health Research | Las Vegas | Nevada | 89119 | — |
| Carolina Advanced Research | Cary | North Carolina | 27511 | — |
| Fallen Timbers Internal Medicine, LLC | Maumee | Ohio | 43537 | — |
| Millenium Research | Benbrook | Texas | 76126 | — |
| Healthsouth Clinical Research | DeSoto | Texas | 75115 | — |
| Baylor College of Medicine/Clinical Studies Unit | Houston | Texas | 77030 | — |
| Diabetes Center of the Southwest | Midland | Texas | 79705 | — |
| Utah Diabetes Center at the University of Utah | Salt Lake City | Utah | 84108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00044694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00044694 live on ClinicalTrials.gov.